Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1683 of 5804
-
Radioactive injection shrinks brain cysts without surgery
Disease control Recruiting nowThere is no consensus in the literature on the best way to treat cystic lesions of the pituitary area. Patients who are symptomatic from these tumours are rare. The cystic form of tumours present special challenges since traditional treatment modalities (surgery and/or external r…
Phase: PHASE3 • Sponsor: David Clarke • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Custom brace and therapy aim to get wounded warriors back on their feet
Disease control CompletedThe goal of the PRIORITI-MTF study is to help determine whether a new type of custom designed brace, called the IDEO ™ along with a physical therapy program, called Return to Run, improves physical function. This brace was developed for wounded warriors who wanted to return to an…
Phase: NA • Sponsor: Major Extremity Trauma Research Consortium • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a 'Love Hormone' spray tame Prader-Willi symptoms?
Symptom relief CompletedThe investigator thinks that the oxytocin (OT) can improve durably and significantly the behavior disorders and thus the socialization but also the satisfaction and could thus be an interesting therapeutic alternative for the patients presenting a Prader-Willi Syndrome (SPW). Alt…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Proton beam therapy aims to spare kids with neuroblastoma from harsh side effects
Disease control Recruiting nowThis research study is evaluating a therapy called proton beam radiation therapy (PBRT) as a possible treatment for neuroblastoma. Neuroblastoma most commonly occurs in and around the adrenal glands, which are located at the top of the kidneys. However, it can also occur in othe…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Gene test guides treatment for rare salivary gland tumors
Disease control CompletedThis is a study of select drug therapies in patients with salivary gland cancer. The study has two phases: a molecular profiling phase (phase 1) and a treatment phase (phase 2). Based on the Molecular profiling results in phase the participants will receive matched treatment if …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental drug duo targets Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of raptor/rictor-mammalian target of rapamycin (mTOR) (TORC1/2) inhibitor MLN0128 when given in combination with bevacizumab in treating patients with glioblastoma, a type of brain tumor, or a solid tumor that has spread a…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of lenalidomide when given together with ibrutinib and rituximab in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma that has come back (relapsed), has not responded well to prior treatment…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heated chemo during surgery may fight ovarian cancer return
Disease control OngoingThis phase I trial studies the side effects and how well surgery and heated chemotherapy with or without non-heated chemotherapy after surgery works in treating patients with ovarian, fallopian tube, uterine, or peritoneal cancer. Giving a dose of heated chemotherapy into the abd…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Which shock drug is safest? large ICU trial aims to find out
Disease control Recruiting nowThe investigators hypothesis is that for ICU patients with shock, the use of the vasoactive drugs phenylephrine and vasopressin will reduce tachydysrhythmias when compared to norepinephrine and epinephrine. To investigate this hypothesis, the investigators are conducting a random…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Turmeric compound tested to stop prostate cancer return
Disease control Recruiting nowThis is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.
Phase: PHASE3 • Sponsor: yair lotan • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Ketamine's secret: family history of alcoholism may boost antidepressant effects
Knowledge-focused Recruiting nowA single subanesthetic dose infusion of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine has rapid and robust antidepressant effects in patients with treatment-refractory major depressive disorder (TRD). A family history of an alcohol use disorder (Family History Posi…
Phase: PHASE2 • Sponsor: Mark Niciu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New cocktail targets tough lymphoma: carfilzomib joins R-ICE in early trial
Disease control OngoingThis phase I/Ib trial studies the side effects and best dose of carfilzomib when given together with rituximab, ifosfamide, carboplatin, and etoposide and to see how well it works in treating patients with stage I-IV diffuse large B-cell lymphoma that has returned (relapsed) or t…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New inhaler combo shows promise for Hard-to-Control asthma
Disease control CompletedPrimary objective The primary objective was to evaluate the efficacy of a free combination of CHF 5259 at 3 dose levels plus Foster® 100/6 μg in a pMDI by comparison with Foster® 100/6 μg in terms of forced expiratory volume in the first second (FEV1) area under the curve betwee…
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Singing together after stroke: a prescription for healing?
Symptom relief Recruiting nowThe study will focus on the impact of communal singing on patients with stroke and their personal caregivers. Forty post-stroke patients will be randomly assigned to two groups: the first group of 20 stroke survivors and their caregivers (up to 40 total participants) will receive…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New checklist aims to slash MRSA infections in veterans after surgery
Disease control CompletedThe goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist w…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Knee pain relief without surgery? collagen injection shows promise
Symptom relief CompletedThe primary objective of this study is to confirm the superiority of intra-articular collagen injection in patients with knee joint pain compared to the control group. 100mm VAS is used to measure the pain of the subjects 24 weeks after the procedure.
Phase: PHASE4 • Sponsor: Cellontech Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Booster shot study aims to keep teens safe from whooping cough
⭐️ VACCINE ⭐️ CompletedThis study is designed to assess the immunogenicity and safety of DTaP vaccine (BK1301) as a booster dose in adolescents. The purposes of this study are as follows: * To confirm the non-inferiority of BK1301 to Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid) with respec…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Can a 5-Day radiation course beat the standard for prostate cancer?
Disease control Recruiting nowPhase 1-2 study, comparing ultra-hypofractionnated (UH) to a moderately hypofractionnated (MH) radiation therapy, with image guided HDR prostate brachytherapy. Using iso-equivalent doses, a non-inferiority analysis will be done in order to prove UH non-inferior to MH, toxicity wi…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 26, 2026 14:45 UTC
-
Can a genetic test pick the best chemo for triple negative breast cancer?
Knowledge-focused CompletedThis is a phase II study randomizing patients with stage I with T1 \> 1.5 cm, stage II or III triple negative breast cancer (TNBC) to preoperative cisplatin versus paclitaxel. The study is designed to evaluate the ability of the Homologous Recombination Deficiency (HRD) assay to …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Could an arthritis drug tame a tough transplant complication?
Disease control CompletedThe participant is invited to take part in this study because they have chronic Graft versus Host Disease (cGVHD) that is not responding to standard treatment with steroids. This research study is a way of gaining new knowledge about the treatment of patients with cGVHD. This res…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC